Phenylethylpyrrolidine
| Names | |
|---|---|
| Preferred IUPAC name
1-(2-Phenylethyl)pyrrolidine | |
| Identifiers | |
3D model (JSmol)
|
|
| ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C12H17N | |
| Molar mass | 175.275 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
1-(2-Phenylethyl)pyrrolidine (PEP) is a chemical compound of the phenethylamine family. It is an analogue of 2-phenylethylamine where the amine has been replaced by a pyrrolidine ring.
Derivatives
The α-methyl (i.e., amphetamine derivative is 1-(α-methylphenethyl)pyrrolidine (MPEP), the β-keto derivative is phenacylpyrrolidine, and the combined α-methyl and β-keto (i.e., cathinone) derivative is α-pyrrolidinopropiophenone (α-PPP).[1] Prolintane is the α-propyl derivative of PEP.[1]
PEP is the base chemical structure for a series of stimulant drugs, including:[1]
All of these compounds differ from PEP in that the alpha carbon is extended and a ketone is attached to the beta carbon (with the exception of prolintane), among other modifications.[1]
A cyclized phenethylamine and 2-aminoindane derivative is Pyr-AI ((2-indanyl)pyrrolidine).[2] It is the analogue of 2-aminoindane (2-AI) in which the amine has been replaced with a pyrrolidine group.[2] The drug has been described as having strong and long-lasting amphetamine-like effects in rodents.[2][3]
See also
References
- ^ a b c d Glennon RA (2014). "Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention". Adv Pharmacol. 69: 581–620. doi:10.1016/B978-0-12-420118-7.00015-9. PMC 4471862. PMID 24484988.
- ^ a b c Brandt, Simon D.; Braithwaite, Robin A.; Evans-Brown, Michael; Kicman, Andrew T. (2013). "Aminoindane Analogues". Novel Psychoactive Substances. Elsevier. p. 261–283. doi:10.1016/b978-0-12-415816-0.00011-0. ISBN 978-0-12-415816-0. Retrieved 2 November 2025.
A 'strong amphetamine-type activity' has been reported for the pyrrolidine derivative of 2-AI (26, Fig. 11.10) [41] and 'a long duration' of activity was observed at the 10mg/kg dose in mice. Details about the procedure were not provided but neuropharmacological screenings were based on observational methods [48]. A piperidine derivative (27, PIP-AI), on the other hand, showed analgesic properties comparable to meperidine [41].
- ^ Solomons E, Sam J (December 1973). "2-Aminoindans of pharmacological interest". J Med Chem. 16 (12): 1330–1333. doi:10.1021/jm00270a004. PMID 4765859.
| Stimulants |
|
|---|---|
| Depressants |
|
| Hallucinogens |
|
| Entactogens |
|
| Psychiatric drugs |
|
| Others |
|